Form 8-K Filing by Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. filed a Form 8-K on March 17, 2026, to report its results of operations for the quarter ended January 31, 2026. The press release announcing these results is furnished as Exhibit 99.1 to the filing. This information is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings unless expressly stated. The filing also includes Exhibit 104, the Cover Page Interactive Data File. The report is signed by Pedro J. Lasanta, CFO, Vice President of Finance and Administration, and Secretary.